Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Noninvasive Detection of ctDNA Reveals Intratumor Heterogeneity and Is Associated with Tumor Burden in Gastrointestinal Stromal Tumor.

Namløs HM, Boye K, Mishkin SJ, Barøy T, Lorenz S, Bjerkehagen B, Stratford EW, Munthe E, Kudlow BA, Myklebost O, Meza-Zepeda LA.

Mol Cancer Ther. 2018 Nov;17(11):2473-2480. doi: 10.1158/1535-7163.MCT-18-0174. Epub 2018 Aug 10.

PMID:
30097488
2.

Preclinical Evaluation of Vemurafenib as Therapy for BRAFV600E Mutated Sarcomas.

Gouravan S, Meza-Zepeda LA, Myklebost O, Stratford EW, Munthe E.

Int J Mol Sci. 2018 Mar 23;19(4). pii: E969. doi: 10.3390/ijms19040969.

3.

Analysis of the miR-34 family functions in breast cancer reveals annotation error of miR-34b.

Engkvist ME, Stratford EW, Lorenz S, Meza-Zepeda LA, Myklebost O, Munthe E.

Sci Rep. 2017 Aug 28;7(1):9655. doi: 10.1038/s41598-017-10189-1.

4.

PP2A Regulatory Subunit B55γ is a Gatekeeper of Osteoblast Maturation and Lineage Maintenance.

Serguienko A, Hanes R, Grad I, Wang MY, Myklebost O, Munthe E.

Stem Cells Dev. 2017 Oct 1;26(19):1375-1383. doi: 10.1089/scd.2017.0129. Epub 2017 Aug 10.

PMID:
28805158
5.

The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma.

Sandhu V, Wedge DC, Bowitz Lothe IM, Labori KJ, Dentro SC, Buanes T, Skrede ML, Dalsgaard AM, Munthe E, Myklebost O, Lingjærde OC, Børresen-Dale AL, Ikdahl T, Van Loo P, Nord S, Kure EH.

Cancer Res. 2016 Sep 1;76(17):5092-102. doi: 10.1158/0008-5472.CAN-16-0658. Epub 2016 Aug 3.

6.

Preclinical evaluation of potential therapeutic targets in dedifferentiated liposarcoma.

Hanes R, Grad I, Lorenz S, Stratford EW, Munthe E, Reddy CC, Meza-Zepeda LA, Myklebost O.

Oncotarget. 2016 Aug 23;7(34):54583-54595. doi: 10.18632/oncotarget.10518.

7.

FDG-based quantitative comparison of glucose metabolism in vitro, exemplified by a head-to-head comparison between a triple-negative breast cancer cell line and a non-malignant foetal cell line.

Munthe E, Riss PJ, Saga TA, Haraldsen I, Grad I, Bogsrud TV, Bach-Gansmo T.

Clin Physiol Funct Imaging. 2018 Jan;38(1):34-37. doi: 10.1111/cpf.12378. Epub 2016 Jun 13.

PMID:
27297457
8.

Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA.

Serguienko A, Grad I, Wennerstrøm AB, Meza-Zepeda LA, Thiede B, Stratford EW, Myklebost O, Munthe E.

Oncotarget. 2015 Feb 10;6(4):2451-65.

9.

Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines.

Wennerström AB, Lothe IM, Sandhu V, Kure EH, Myklebost O, Munthe E.

PLoS One. 2014 Aug 22;9(8):e103873. doi: 10.1371/journal.pone.0103873. eCollection 2014.

10.

The tankyrase-specific inhibitor JW74 affects cell cycle progression and induces apoptosis and differentiation in osteosarcoma cell lines.

Stratford EW, Daffinrud J, Munthe E, Castro R, Waaler J, Krauss S, Myklebost O.

Cancer Med. 2014 Feb;3(1):36-46. doi: 10.1002/cam4.170. Epub 2013 Dec 17.

11.

Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes.

Lauvrak SU, Munthe E, Kresse SH, Stratford EW, Namløs HM, Meza-Zepeda LA, Myklebost O.

Br J Cancer. 2013 Oct 15;109(8):2228-36. doi: 10.1038/bjc.2013.549. Epub 2013 Sep 24.

12.

Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines.

Wang P, Gao Q, Suo Z, Munthe E, Solberg S, Ma L, Wang M, Westerdaal NA, Kvalheim G, Gaudernack G.

PLoS One. 2013;8(3):e57020. doi: 10.1371/journal.pone.0057020. Epub 2013 Mar 4.

13.

Characterization of liposarcoma cell lines for preclinical and biological studies.

Stratford EW, Castro R, Daffinrud J, Skårn M, Lauvrak S, Munthe E, Myklebost O.

Sarcoma. 2012;2012:148614. doi: 10.1155/2012/148614. Epub 2012 Jul 14.

14.

Liposarcoma Cells with Aldefluor and CD133 Activity have a Cancer Stem Cell Potential.

Stratford EW, Castro R, Wennerstrom A, Holm R, Munthe E, Lauvrak S, Bjerkehagen B, Myklebost O.

Clin Sarcoma Res. 2011 Aug 1;1(1):8. doi: 10.1186/2045-3329-1-8. Epub 2011 Aug 1.

15.

Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells.

Stronen E, Abrahamsen IW, Gaudernack G, Wälchli S, Munthe E, Buus S, Johansen FE, Lund-Johansen F, Olweus J.

Scand J Immunol. 2009 Apr;69(4):319-28. doi: 10.1111/j.1365-3083.2008.02223.x.

16.

beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.

Nygren MK, Døsen-Dahl G, Stubberud H, Wälchli S, Munthe E, Rian E.

Exp Hematol. 2009 Feb;37(2):225-33. doi: 10.1016/j.exphem.2008.10.007. Epub 2008 Dec 20. Erratum in: Exp Hematol. 2009 Mar;37(3):421.

PMID:
19101069
17.

Bone marrow stroma cells regulate TIEG1 expression in acute lymphoblastic leukemia cells: role of TGFbeta/BMP-6 and TIEG1 in chemotherapy escape.

Døsen-Dahl G, Munthe E, Nygren MK, Stubberud H, Hystad ME, Rian E.

Int J Cancer. 2008 Dec 15;123(12):2759-66. doi: 10.1002/ijc.23833. Erratum in: Int J Cancer. 2009 May 1;24(9):2250.

18.

Characterization of early stages of human B cell development by gene expression profiling.

Hystad ME, Myklebust JH, Bø TH, Sivertsen EA, Rian E, Forfang L, Munthe E, Rosenwald A, Chiorazzi M, Jonassen I, Staudt LM, Smeland EB.

J Immunol. 2007 Sep 15;179(6):3662-71. Erratum in: J Immunol. 2009 May1;182(9):5882.

20.
21.

Characterization of a novel human endogenous retrovirus, HERV-H/F, expressed in human leukemia cell lines.

Patzke S, Lindeskog M, Munthe E, Aasheim HC.

Virology. 2002 Nov 10;303(1):164-73.

22.

Characterization of the human ephrin-A4 promoter.

Munthe E, Aasheim HC.

Biochem J. 2002 Sep 1;366(Pt 2):447-58.

23.

Ephrin-B2 is a candidate ligand for the Eph receptor, EphB6.

Munthe E, Rian E, Holien T, Rasmussen A, Levy FO, Aasheim H.

FEBS Lett. 2000 Jan 21;466(1):169-74.

24.

Recent onset arthritis in the elderly: a 5 year longitudinal observational study.

Glennås A, Kvien TK, Andrup O, Karstensen B, Munthe E.

J Rheumatol. 2000 Jan;27(1):101-8.

PMID:
10648025
25.

A splice variant of human ephrin-A4 encodes a soluble molecule that is secreted by activated human B lymphocytes.

Aasheim HC, Munthe E, Funderud S, Smeland EB, Beiske K, Logtenberg T.

Blood. 2000 Jan 1;95(1):221-30.

26.

Molecular cloning of a T cell-specific adapter protein (TSAd) containing an Src homology (SH) 2 domain and putative SH3 and phosphotyrosine binding sites.

Spurkland A, Brinchmann JE, Markussen G, Pedeutour F, Munthe E, Lea T, Vartdal F, Aasheim HC.

J Biol Chem. 1998 Feb 20;273(8):4539-46.

27.
28.

C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis.

Olmez U, Garred P, Mollnes TE, Harboe M, Berntzen HB, Munthe E.

Scand J Rheumatol. 1991;20(3):183-9.

PMID:
2068540
29.

The leukocyte protein L1 in plasma and synovial fluid from patients with rheumatoid arthritis and osteoarthritis.

Berntzen HB, Olmez U, Fagerhol MK, Munthe E.

Scand J Rheumatol. 1991;20(2):74-82.

PMID:
1709519
30.

Rheumatoid arthritis may be primarily associated with HLA-DR4 molecules sharing a particular sequence at residues 67-74.

Rønningen KS, Spurkland A, Egeland T, Iwe T, Munthe E, Vartdal F, Thorsby E.

Tissue Antigens. 1990 Nov;36(5):235-40.

PMID:
2095004
31.
32.

The B cell system in the rheumatoid inflammation. New insights into the pathogenesis of rheumatoid arthritis using synovial B cell hybridoma clones.

Natvig JB, Randen I, Thompson K, Førre O, Munthe E.

Springer Semin Immunopathol. 1989;11(3):301-13. Review. No abstract available.

PMID:
2694403
33.

[Rheumatoid arthritis and Bechterew's disease. Guidelines for diagnosis and treatment].

Glennås A, Andrup O, Kvien TK, Munthe E.

Tidsskr Nor Laegeforen. 1988 Sep 20;108(26):2143-6. Norwegian. No abstract available.

PMID:
3206416
34.

The major leukocyte protein L1 as an indicator of inflammatory joint disease.

Berntzen HB, Munthe E, Fagerhol MK.

Scand J Rheumatol Suppl. 1988;76:251-6.

PMID:
3251353
35.

Relationship Between IgG Complexes and ANTMgG Antibodies in Rheumatoid Arthritis.

Munthe E.

Scand J Rheumatol. 1987;16(1):240-56. doi: 10.3109/03009747009165377.

PMID:
20144115
36.

The cervical spine in rheumatoid arthritis.

Munthe E.

Scand J Rheumatol. 1987;16(1):7. No abstract available.

PMID:
3589592
37.

The influence of D-penicillamine on trace element excretion.

Bibow K, Salbu B, Strand KM, Munthe E.

Acta Pharmacol Toxicol (Copenh). 1986;59 Suppl 7:374-7. No abstract available.

PMID:
3776591
38.

Analysis of cellular and membrane extracts of human leukocytes from rheumatoid arthritis patients using two-dimensional electrophoresis.

Berner Berntzen H, Willard-Gallo KE, Munthe E, Jellum E.

Scand J Clin Lab Invest Suppl. 1986;184:77-83.

PMID:
3473615
39.

Trace elements and rheumatoid arthritis (RA)--pathogenetic and therapeutic aspects.

Munthe E, Aaseth J, Jellum E.

Acta Pharmacol Toxicol (Copenh). 1986;59 Suppl 7:365-73.

PMID:
3022551
40.

[Importance of rheumatoid factors in joint inflammation in rheumatoid arthritis].

Munthe E, Egeland T.

Ter Arkh. 1984;56(5):10-4. Russian. No abstract available.

PMID:
6463874
41.

[Trace elements and metalloproteins in rheumatoid arthritis].

Aaseth J, Thomassen Y, Førre O, Dobloug J, Munthe E, Jellum E.

Tidsskr Nor Laegeforen. 1983 Aug 30;103(24):1694-6. Norwegian. No abstract available.

PMID:
6636085
42.

[Immunomodulating drugs in rheumatic diseases in adults and children].

Salvesen CF, Kvien TK, Førre O, Kåss E, Fauchald P, Munthe E.

Tidsskr Nor Laegeforen. 1983 Apr 10;103(10):829-32. Norwegian. No abstract available.

PMID:
6603676
43.

The role of the laboratory in rheumatology. Rheumatoid factors.

Egeland T, Munthe E.

Clin Rheum Dis. 1983 Apr;9(1):135-60. No abstract available.

PMID:
6347504
44.

Is gold necessary in so called chrysotherapy?

Munthe E, Jellum E.

Scand J Rheumatol Suppl. 1983;51:46-51. Review.

PMID:
6426053
45.
46.

Two-dimensional electrophoretic analysis of human leukocyte proteins from patients with rheumatoid arthritis.

Willard KE, Thorsrud AK, Munthe E, Jellum E.

Clin Chem. 1982 Apr;28(4 Pt 2):1067-73.

47.

Physical activity in the treatment of inflammatory rheumatic disorders.

Bjørholt PG, Høyeraal HM, Munthe E, Pahle J, Kogstad O, Sydnes OA, Ziesler J.

Scand J Soc Med Suppl. 1982;29:235-9.

PMID:
6982508
48.

[Trace elements in "health food" and in hospital diets].

Salbu B, Jacobsen E, Munthe E, Jellum E, Gran F.

Tidsskr Nor Laegeforen. 1981 Jun 20;101(17-18):1050-2. Norwegian. No abstract available.

PMID:
7281121
49.
50.

Penicillamine in rheumatic diseases: a prospective study of tolerance and efficacy.

Munthe E, Kåss E.

J Rheumatol Suppl. 1981 Jan-Feb;7:107-11.

PMID:
6785435

Supplemental Content

Loading ...
Support Center